MedPath

Comparing the clinical response of obsessive-compulsive patients refractory to serotonin reuptake inhibitor regimen with and without lamotrigine; a double-blind placebo controlled study

Phase 2
Conditions
Obsessive-compulsive patients.
The essential feature is recurrent obsessional thoughts or compulsive acts.
Registration Number
IRCT2014031717045N1
Lead Sponsor
Guilan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

OCD diagnosis on axis I based on DSM IV TR; Ages between 16 and 60; Yale Brown Obsessive Compulsive Score of more than 21

Exclusion criteria: Active psychotic disorder such as schizophrenia, psychotic bipolar disorder and major depressive disorder; Major organic disorder; Organic brain disorder; Drug and substance abuse; Mental retardation; Pregnancy and lactation; During psychotherapy

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical response is measured by Yale Brown Obsessive Compulsive Scale. Timepoint: The day 0, 60 and 90. Method of measurement: Yale Brown Obsessive Compulsive Scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath